N/A
N=330
The Effect of a Contingency Management Intervention on Substance Use
Substance Use Disorders
Bottom Line
View on ClinicalTrials.gov: NCT00252512 ↗Enrolled (actual)
330
Serious AEs
30.9%
Results posted
Aug 2014
Primary outcome: Primary: Number of Negative Breath Alcohol and Urine Drug Screens Out of Possible 16 — 11.93; 10.39 negative alcohol and drug screens — p=<.001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Contingency Management (Behavioral); Placebo (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Jan 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Negative Breath Alcohol and Urine Drug Screens Out of Possible 16 |
11.93; 10.39 | <.001 sig |
| SECONDARY Psychiatric Status |
20.87; 18.90; 20.64; 20.19; 21.06; 19.07 | .015 sig |
| SECONDARY VHA Healthcare Service Utilization |
12744.44; 16456.32; 8934.52; 8386.94 | >.05 |
| SECONDARY Housing |
77; 66; 80; 91; 88; 88 | .28 |
| SECONDARY Legal Status |
3; 2; 6; 3; 3; 7 | .66 |
| SECONDARY Employment Status |
74; 57; 51; 49; 32; 43 | .05 |
Summary
Contingency management interventions involve providing a tangible reward for progress toward treatment goals. The purpose of this study is to determine whether a contingency management intervention added to usual care leads to improved attendance and decreased substance use in patients attending outpatient substance use disorders treatment.
Eligibility Criteria
Inclusion Criteria
- veterans presenting for outpatient substance use disorders treatment with a diagnosis of alcohol, cocaine, amphetamine, or methamphetamine dependence
Exclusion Criteria
- primary cannabis dependence
- primary opioid dependence
- severe psychiatric symptoms
- suicide risk
- positive history or screen for pathological gambling
- lacking transportation or living too far away to attend twice per week research appointments
Data sourced from ClinicalTrials.gov (NCT00252512). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.